- Current report filing (8-K)
10 June 2009 - 6:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 OR 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
June 9,
2009
BRUKER CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
(State or other
jurisdiction
of incorporation)
|
|
000-30833
(Commission
File Number)
|
|
04-3110160
(IRS Employer
Identification No.)
|
40
Manning Road
Billerica,
MA 01821
(Address of
principal executive offices)(Zip Code)
Registrants
telephone number, including area code:
(978) 663-3660
Check
the appropriate box if the Form 8-K filing is intended to simultaneously
satisfy the reporting obligation of the registrant under any of the following
provisions:
o
|
|
Written
communications pursuant to Rule 425 under the Securities Act
|
o
|
|
Soliciting
material pursuant to Rule 14a-12 of the Exchange Act
|
o
|
|
Pre-commencement
communications pursuant to Rule 14d-2(b) Exchange Act
|
o
|
|
Pre-commencement
communications pursuant to Rule 13e-4(c) Exchange Act
|
Item 7.01 Regulation
FD Disclosure.
On June 9, 2009, Bruker Corporation (the Company)
will present at the Goldman Sachs 30
th
Annual Global Healthcare Conference in New
York, New York. The presentation
materials, a copy of which are attached hereto as Exhibit 99.1, on slides
5 through 7 contain certain previously non-public information.
The slides attached to this Current Report on Form 8-K
as Exhibit 99.1 are also posted on the Companys investor relations
website at http://www.bruker.com.
The
information in this Current Report on Form 8-K, including exhibits
attached hereto, is being furnished and shall not be deemed filed for purposes
of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange
Act), or otherwise sub
ject to the liabilities of that Section and
shall not be deemed incorporated by reference into any filing by the Company
under the Securities Act of 1933, as amended, or the Exchange Act, unless
specifically identified therein as being incorporated by reference therein.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. 99.1
June 9, 2009 PowerPoint
Presentation
2
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
BRUKER CORPORATION
|
|
|
(Registrant)
|
|
|
|
|
Date: June 9, 2009
|
|
By:
|
/s/ William J. Knight
|
|
|
|
William J.
Knight
|
|
|
|
Chief
Financial Officer
|
3
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024